Skip to content
411 PRESS
WarningRecall #26455

Bayer Recalls 6 mL Size Afrin Original Nasal Spray Bottles Due to Risk of Serious Injury or Illness from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

Bayer HealthCare LLC, of Whippany, New Jersey · Travel Size Afrin® Original Nasal Spray 6 mL Bottles

Recalled Travel Size Afrin® Original Nasal Spray 6 mL Bottles (image 1 of 2)
Recalled Travel Size Afrin® Original Nasal Spray 6 mL Bottles (image 1 of 2) Photo: CPSC / Public Domain
Recalled Travel Size Afrin® Original Nasal Spray 6 mL Bottles (image 2 of 2)
Recalled Travel Size Afrin® Original Nasal Spray 6 mL Bottles (image 2 of 2) Photo: CPSC / Public Domain

Product Description

This recall involves unexpired Travel Size Afrin® Original Nasal Spray 6 mL bottles, with Lot numbers 230361, 240822, 241198, 250066, 250152, 250646, and 250831. These travel size bottles have "Afrin® Original Nasal Spray" and "1/5 FL OZ (6 mL)" printed on a label located on the front of the bottle. It is a six-digit number, followed by the expiration date in following format: "YYYYMMM". No other sizes of Afrin are included in this recall.

Hazard

The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children.

Remedy

Consumers should immediately secure the recalled bottles out of sight and reach of children and go to the webform posted on www.livewell.bayer.com/afrin-original-spray-recall to begin a request for a refund. Consumers will be asked to take and submit a photo of the product before disposing of it in order to receive a refund.

Refund

411 Press Analysis

The CPSC issued a recall for Travel Size Afrin® Original Nasal Spray 6 mL Bottles on April 30, 2026, covering about 786,100. The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. None reported Bayer HealthCare LLC, of Whippany, New Jersey is offering affected consumers the opportunity to obtain a full refund. Consumers should stop using the product and contact the manufacturer for instructions. The CPSC recommends checking purchase history and product labels to determine if your unit is affected.

Independent news on labor, safety, and accountability.